LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 31 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,988,000 | -2.2% | 40,000,000 | 0.0% | 1.44% | +6.3% |
| Q4 2021 | $39,863,000 | -0.8% | 40,000,000 | 0.0% | 1.36% | -4.0% |
| Q3 2021 | $40,182,000 | +1.5% | 40,000,000 | 0.0% | 1.41% | -3.9% |
| Q2 2021 | $39,571,000 | -19.7% | 40,000,000 | -15.8% | 1.47% | -24.8% |
| Q1 2021 | $49,299,000 | -12.8% | 47,500,000 | -20.8% | 1.96% | -19.8% |
| Q4 2020 | $56,517,000 | +4.1% | 60,000,000 | 0.0% | 2.44% | +21.0% |
| Q3 2020 | $54,281,000 | +3.0% | 60,000,000 | 0.0% | 2.02% | +14.4% |
| Q2 2020 | $52,680,000 | +6.0% | 60,000,000 | 0.0% | 1.76% | +0.3% |
| Q1 2020 | $49,708,000 | -11.5% | 60,000,000 | -7.7% | 1.76% | +34.1% |
| Q4 2019 | $56,160,000 | -2.7% | 65,000,000 | -5.8% | 1.31% | +5.1% |
| Q3 2019 | $57,704,000 | -3.9% | 69,000,000 | -1.4% | 1.25% | +2.3% |
| Q2 2019 | $60,020,000 | – | 70,000,000 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |